BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2005
View Archived Issues
Iptakalim holds promise for pulmonary hypertension treatment
Read More
Profile of novel antipsychotic agent SLV-314, a D2 antagonist/serotonin reuptake inhibitor
Read More
LT-1951 reported safe in patients undergoing CABG surgery
Read More
Studies confirm the antitumor effects of INGN-241 in metastatic melanoma
Read More
New data on the efficacy of aselizumab in psoriasis
Read More
A sunflower oleodistillate shows promise in the treatment of atopic dermatitis
Read More
CombinatoRx and Angiotech sign research and license agreement
Read More
Dainippon and Sumitomo create Dainippon Sumitomo Pharma
Read More
MGI Pharma completes acquisition of Guilford
Read More
Salix and InKine complete merger
Read More
Innogenetics extends collaboration with IDM Pharma
Read More
Elusys to study Anthim for anthrax in phase I study
Read More
Depomed delivers notice of breach to Biovail
Read More
Astellas and MerLion sign drug discovery agreement
Read More
Phase I protocol submitted for Stem Cells Therapeutics' stroke program
Read More
Phase II studies planned for Oxycyte
Read More
N-Butyrylglucosamine shows efficacy in experimental models of arthritis
Read More
Novel agents for diabetes and related complications reported in recent patent literature
Read More
Humira approved for new rheumatoid arthritis indication and psoriatic arthritis
Read More
European approval for shorter course of Peg-Intron and Rebetol
Read More
Long-term effects and safety of ambrisentan in PAH patients
Read More
Approvable letter for Zelapar
Read More
Ispronicline improves cognition in patients with mild impairment
Read More
Innovive to begin phase I trials with INNO-105 for solid malignancies
Read More
Recent Theravance patent discloses novel 5-HT4 receptor agonists for gastrointestinal disorders
Read More
Novel therapeutics for cardiovascular diseases reported
Read More
